These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29958235)

  • 1. Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma.
    Schmidt M; Segev Y; Sadeh R; Suzan E; Feferkorn I; Kaldawy A; Kligun G; Lavie O
    Int J Gynecol Cancer; 2018 Sep; 28(7):1311-1317. PubMed ID: 29958235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients.
    Roelofsen T; Mingels M; Hendriks JC; Samlal RA; Snijders MP; Aalders AL; Bulten J; van Ham MA; Massuger LF
    Int J Biol Markers; 2012 Oct; 27(3):e263-71. PubMed ID: 22865295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
    Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
    Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma.
    Gupta D; Gunter MJ; Yang K; Lee S; Zuckerwise L; Chen LM; Goldberg GL; Huang GS
    Int J Gynecol Cancer; 2011 Apr; 21(3):529-34. PubMed ID: 21436701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer.
    Frimer M; Hou JY; McAndrew TC; Goldberg GL; Shahabi S
    Reprod Sci; 2013 Apr; 20(4):449-55. PubMed ID: 22995987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
    Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
    Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.
    Baek MH; Lee SW; Park JY; Kim D; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2015 Jan; 25(1):69-74. PubMed ID: 25470688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    Kwon JS; Abrams J; Sugimoto A; Carey MS
    Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cytology in serous and endometrioid endometrial cancer.
    Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
    Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
    Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
    Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
    Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
    Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
    Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma.
    Solmaz U; Ekin A; Mat E; Gezer C; Dogan A; Biler A; Peker N; Hasdemir PS; Sanci M
    Tumori; 2016 Dec; 102(6):593-599. PubMed ID: 27514313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.
    Chan JK; Loizzi V; Youssef M; Osann K; Rutgers J; Vasilev SA; Berman ML
    Gynecol Oncol; 2003 Jul; 90(1):181-5. PubMed ID: 12821361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
    Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
    Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.